Selected research
Industry Research
Clavulanic Acid (API) Industry Research Report 2026
Market perspective
Global Clavulanic Acid key players include GSK, Novartis, Sinopharm Sandwich Dayao Ye Ltd., Shandong New Time Pharmaceutical, Teva Pharmaceutical Industries Limited, United Laboratories, CSPC Pharmaceutical, Sun Pharmaceutical Industries Ltd., NCPC, etc.
Report Scope
This report quantifies the global Clavulanic Acid (API) market in revenue (US$ million) and, where applicable, sales volume (kt), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
Read the full market overview
It standardizes definitions of types and applications, harmonizes vendor attribution, and presents comparable time series by company, type, application, and region/country, including indicative price bands (US$/kt) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for manufacturers, new entrants, channel partners, and investors; the report also reviews technology shifts and notable product introductions relevant to Clavulanic Acid (API).
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Clavulanic Acid (API) Market by Company
GSK
Novartis
Sinopharm Sandwich Dayao Ye Ltd.
Shandong New Time Pharmaceutical
Teva Pharmaceutical Industries Limited
United Laboratories
CSPC Pharmaceutical
Sun Pharmaceutical Industries Ltd.
NCPC
Clavulanic Acid (API) Segment by Type
1:1
2:1
4:1
Others
Clavulanic Acid (API) Segment by Application
Combined with Amoxicillin
Combined with Ticarcillin
Clavulanic Acid (API) Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Clavulanic Acid (API) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Clavulanic Acid (API) and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Clavulanic Acid (API).
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Clavulanic Acid (API) manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Clavulanic Acid (API) by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Clavulanic Acid (API) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 1:1
- 2:1
- 4:1
- Others
Applications
- Combined with Amoxicillin
- Combined with Ticarcillin
Companies covered
- GSK
- Novartis
- Sinopharm Sandwich Dayao Ye Ltd.
- Shandong New Time Pharmaceutical
- Teva Pharmaceutical Industries Limited
- United Laboratories
- CSPC Pharmaceutical
- Sun Pharmaceutical Industries Ltd.
- NCPC
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Clavulanic Acid (API) by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.2.2 1:1
- 2.2.3 2:1
- 2.2.4 4:1
- 2.2.5 Others
- 2.3 Clavulanic Acid (API) by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Combined with Amoxicillin
- 2.3.3 Combined with Ticarcillin
- 2.4 Global Market Growth Prospects
- 2.4.1 Global Clavulanic Acid (API) Production Value Estimates and Forecasts (2021-2032)
- 2.4.2 Global Clavulanic Acid (API) Production Capacity Estimates and Forecasts (2021-2032)
- 2.4.3 Global Clavulanic Acid (API) Production Estimates and Forecasts (2021-2032)
- 2.4.4 Global Clavulanic Acid (API) Market Average Price (2021-2032)
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Clavulanic Acid (API) Production by Manufacturers (2021-2026)
- 3.2 Global Clavulanic Acid (API) Production Value by Manufacturers (2021-2026)
- 3.3 Global Clavulanic Acid (API) Average Price by Manufacturers (2021-2026)
- 3.4 Global Clavulanic Acid (API) Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Clavulanic Acid (API) Key Manufacturers, Manufacturing Sites & Headquarters
- 3.6 Global Clavulanic Acid (API) Manufacturers, Product Type & Application
- 3.7 Global Clavulanic Acid (API) Manufacturers Established Date
- 3.8 Global Clavulanic Acid (API) Market CR5 and HHI
- 3.9 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 GSK
- 4.1.1 GSK Clavulanic Acid (API) Company Information
- 4.1.2 GSK Clavulanic Acid (API) Business Overview
- 4.1.3 GSK Clavulanic Acid (API) Production Capacity, Value and Gross Margin (2021-2026)
- 4.1.4 GSK Product Portfolio
- 4.1.5 GSK Recent Developments
- 4.2 Novartis
- 4.2.1 Novartis Clavulanic Acid (API) Company Information
- 4.2.2 Novartis Clavulanic Acid (API) Business Overview
- 4.2.3 Novartis Clavulanic Acid (API) Production Capacity, Value and Gross Margin (2021-2026)
- 4.2.4 Novartis Product Portfolio
- 4.2.5 Novartis Recent Developments
- 4.3 Sinopharm Sandwich Dayao Ye Ltd.
- 4.3.1 Sinopharm Sandwich Dayao Ye Ltd. Clavulanic Acid (API) Company Information
- 4.3.2 Sinopharm Sandwich Dayao Ye Ltd. Clavulanic Acid (API) Business Overview
- 4.3.3 Sinopharm Sandwich Dayao Ye Ltd. Clavulanic Acid (API) Production Capacity, Value and Gross Margin (2021-2026)
- 4.3.4 Sinopharm Sandwich Dayao Ye Ltd. Product Portfolio
- 4.3.5 Sinopharm Sandwich Dayao Ye Ltd. Recent Developments
- 4.4 Shandong New Time Pharmaceutical
- 4.4.1 Shandong New Time Pharmaceutical Clavulanic Acid (API) Company Information
- 4.4.2 Shandong New Time Pharmaceutical Clavulanic Acid (API) Business Overview
- 4.4.3 Shandong New Time Pharmaceutical Clavulanic Acid (API) Production Capacity, Value and Gross Margin (2021-2026)
- 4.4.4 Shandong New Time Pharmaceutical Product Portfolio
- 4.4.5 Shandong New Time Pharmaceutical Recent Developments
- 4.5 Teva Pharmaceutical Industries Limited
- 4.5.1 Teva Pharmaceutical Industries Limited Clavulanic Acid (API) Company Information
- 4.5.2 Teva Pharmaceutical Industries Limited Clavulanic Acid (API) Business Overview
- 4.5.3 Teva Pharmaceutical Industries Limited Clavulanic Acid (API) Production Capacity, Value and Gross Margin (2021-2026)
- 4.5.4 Teva Pharmaceutical Industries Limited Product Portfolio
- 4.5.5 Teva Pharmaceutical Industries Limited Recent Developments
- 4.6 United Laboratories
- 4.6.1 United Laboratories Clavulanic Acid (API) Company Information
- 4.6.2 United Laboratories Clavulanic Acid (API) Business Overview
- 4.6.3 United Laboratories Clavulanic Acid (API) Production Capacity, Value and Gross Margin (2021-2026)
- 4.6.4 United Laboratories Product Portfolio
- 4.6.5 United Laboratories Recent Developments
- 4.7 CSPC Pharmaceutical
- 4.7.1 CSPC Pharmaceutical Clavulanic Acid (API) Company Information
- 4.7.2 CSPC Pharmaceutical Clavulanic Acid (API) Business Overview
- 4.7.3 CSPC Pharmaceutical Clavulanic Acid (API) Production Capacity, Value and Gross Margin (2021-2026)
- 4.7.4 CSPC Pharmaceutical Product Portfolio
- 4.7.5 CSPC Pharmaceutical Recent Developments
- 4.8 Sun Pharmaceutical Industries Ltd.
- 4.8.1 Sun Pharmaceutical Industries Ltd. Clavulanic Acid (API) Company Information
- 4.8.2 Sun Pharmaceutical Industries Ltd. Clavulanic Acid (API) Business Overview
- 4.8.3 Sun Pharmaceutical Industries Ltd. Clavulanic Acid (API) Production Capacity, Value and Gross Margin (2021-2026)
- 4.8.4 Sun Pharmaceutical Industries Ltd. Product Portfolio
- 4.8.5 Sun Pharmaceutical Industries Ltd. Recent Developments
- 4.9 NCPC
- 4.9.1 NCPC Clavulanic Acid (API) Company Information
- 4.9.2 NCPC Clavulanic Acid (API) Business Overview
- 4.9.3 NCPC Clavulanic Acid (API) Production Capacity, Value and Gross Margin (2021-2026)
- 4.9.4 NCPC Product Portfolio
- 4.9.5 NCPC Recent Developments
5 Global Clavulanic Acid (API) Production by Region
- 5.1 Global Clavulanic Acid (API) Production Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 5.2 Global Clavulanic Acid (API) Production by Region: 2021-2032
- 5.2.1 Global Clavulanic Acid (API) Production by Region: 2021-2026
- 5.2.2 Global Clavulanic Acid (API) Production Forecast by Region (2027-2032)
- 5.3 Global Clavulanic Acid (API) Production Value Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 5.4 Global Clavulanic Acid (API) Production Value by Region: 2021-2032
- 5.4.1 Global Clavulanic Acid (API) Production Value by Region: 2021-2026
- 5.4.2 Global Clavulanic Acid (API) Production Value Forecast by Region (2027-2032)
- 5.5 Global Clavulanic Acid (API) Market Price Analysis by Region (2021-2026)
- 5.6 Global Clavulanic Acid (API) Production and Value, YOY Growth
- 5.6.1 North America Clavulanic Acid (API) Production Value Estimates and Forecasts (2021-2032)
- 5.6.2 Europe Clavulanic Acid (API) Production Value Estimates and Forecasts (2021-2032)
- 5.6.3 China Clavulanic Acid (API) Production Value Estimates and Forecasts (2021-2032)
- 5.6.4 Japan Clavulanic Acid (API) Production Value Estimates and Forecasts (2021-2032)
6 Global Clavulanic Acid (API) Consumption by Region
- 6.1 Global Clavulanic Acid (API) Consumption Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 6.2 Global Clavulanic Acid (API) Consumption by Region (2021-2032)
- 6.2.1 Global Clavulanic Acid (API) Consumption by Region: 2021-2026
- 6.2.2 Global Clavulanic Acid (API) Forecasted Consumption by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Clavulanic Acid (API) Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Clavulanic Acid (API) Consumption by Country (2021-2032)
- 6.3.3 United States
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Clavulanic Acid (API) Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Clavulanic Acid (API) Consumption by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Russia
- 6.4.8 Spain
- 6.4.9 Netherlands
- 6.4.10 Switzerland
- 6.4.11 Sweden
- 6.4.12 Poland
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Clavulanic Acid (API) Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Clavulanic Acid (API) Consumption by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 India
- 6.5.7 Australia
- 6.5.8 Taiwan
- 6.5.9 Southeast Asia
- 6.6 South America, Middle East & Africa
- 6.6.1 South America, Middle East & Africa Clavulanic Acid (API) Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East & Africa Clavulanic Acid (API) Consumption by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 Argentina
- 6.6.5 Chile
- 6.6.6 Turkey
- 6.6.7 GCC Countries
7 Segment by Type
- 7.1 Global Clavulanic Acid (API) Production by Type (2021-2032)
- 7.1.1 Global Clavulanic Acid (API) Production by Type (2021-2032) & (kt)
- 7.1.2 Global Clavulanic Acid (API) Production Market Share by Type (2021-2032)
- 7.2 Global Clavulanic Acid (API) Production Value by Type (2021-2032)
- 7.2.1 Global Clavulanic Acid (API) Production Value by Type (2021-2032) & (US$ Million)
- 7.2.2 Global Clavulanic Acid (API) Production Value Market Share by Type (2021-2032)
- 7.3 Global Clavulanic Acid (API) Price by Type (2021-2032)
8 Segment by Application
- 8.1 Global Clavulanic Acid (API) Production by Application (2021-2032)
- 8.1.1 Global Clavulanic Acid (API) Production by Application (2021-2032) & (kt)
- 8.1.2 Global Clavulanic Acid (API) Production Market Share by Application (2021-2032)
- 8.2 Global Clavulanic Acid (API) Production Value by Application (2021-2032)
- 8.2.1 Global Clavulanic Acid (API) Production Value by Application (2021-2032) & (US$ Million)
- 8.2.2 Global Clavulanic Acid (API) Production Value Market Share by Application (2021-2032)
- 8.3 Global Clavulanic Acid (API) Price by Application (2021-2032)
9 Value Chain and Sales Channels Analysis of the Market
- 9.1 Clavulanic Acid (API) Value Chain Analysis
- 9.1.1 Clavulanic Acid (API) Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Clavulanic Acid (API) Production Mode & Process
- 9.2 Clavulanic Acid (API) Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Clavulanic Acid (API) Distributors
- 9.2.3 Clavulanic Acid (API) Customers
10 Global Clavulanic Acid (API) Analyzing Market Dynamics
- 10.1 Clavulanic Acid (API) Industry Trends
- 10.2 Clavulanic Acid (API) Industry Drivers
- 10.3 Clavulanic Acid (API) Industry Opportunities and Challenges
- 10.4 Clavulanic Acid (API) Industry Restraints
11 Report Conclusion
12 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst